Back to rounds

Company profile

Sling Therapeutics

Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.

Location
Ann Arbor, Michigan, United States, North America
Website
slingtx.com

Latest known funding

Series C round

Capital
$123M
Announced
Sep 16, 2026

Participating investors